Sign Out
Treatment of oestrogen deficiency symptoms in postmenopausal women, more than one year after menopause.
Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis (see Pharmacology: Pharmacodynamics under Actions).
For all women the decision to prescribe Livial should be based on an assessment of the individual patient's overall risks and, particularly in the over 60s, should include consideration of the risk of stroke (see Precautions and Adverse Reactions).
